Retreatment with sofosbuvir plus grazoprevir plus elbasvir plus ribavirin of patients with Hepatitis C virus Genotype 1 or 4 with RASs at failure of a sofosbuvir plus ledipasvir or plus daclatasvir or plus simeprevir regimen (ANRS HC34 REVENGE study)

Authors
Publication date
1 January 2017
Publisher
Wiley-Blackwell

Abstract

International audience67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) - Boston, MA - 2016-11-1

    Similar works

    Full text

    thumbnail-image

    Available Versions

    HAL-UNICE

    redirect
    oaioai:HAL:hal-01487921v1
    Last time updated on 13/04/2017

    HAL-Rennes 1

    redirect
    oaioai:HAL:hal-01487921v1
    Last time updated on 15/06/2017

    Hal-Diderot

    redirect
    oaioai:HAL:hal-01487921v1
    Last time updated on 14/04/2021

    HAL - UPEC / UPEM

    redirect
    oaioai:HAL:hal-01487921v1
    Last time updated on 07/05/2019